1. Home
  2. RCUS vs GRC Comparison

RCUS vs GRC Comparison

Compare RCUS & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • GRC
  • Stock Information
  • Founded
  • RCUS 2015
  • GRC 1933
  • Country
  • RCUS United States
  • GRC United States
  • Employees
  • RCUS N/A
  • GRC N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • GRC Fluid Controls
  • Sector
  • RCUS Health Care
  • GRC Industrials
  • Exchange
  • RCUS Nasdaq
  • GRC Nasdaq
  • Market Cap
  • RCUS 1.2B
  • GRC 1.1B
  • IPO Year
  • RCUS 2018
  • GRC N/A
  • Fundamental
  • Price
  • RCUS $12.03
  • GRC $43.58
  • Analyst Decision
  • RCUS Buy
  • GRC
  • Analyst Count
  • RCUS 8
  • GRC 0
  • Target Price
  • RCUS $20.71
  • GRC N/A
  • AVG Volume (30 Days)
  • RCUS 711.9K
  • GRC 58.9K
  • Earning Date
  • RCUS 11-05-2025
  • GRC 10-24-2025
  • Dividend Yield
  • RCUS N/A
  • GRC 1.71%
  • EPS Growth
  • RCUS N/A
  • GRC 51.35
  • EPS
  • RCUS N/A
  • GRC 1.97
  • Revenue
  • RCUS $262,000,000.00
  • GRC $673,880,000.00
  • Revenue This Year
  • RCUS N/A
  • GRC $4.94
  • Revenue Next Year
  • RCUS N/A
  • GRC $4.47
  • P/E Ratio
  • RCUS N/A
  • GRC $21.98
  • Revenue Growth
  • RCUS 6.07
  • GRC 2.60
  • 52 Week Low
  • RCUS $6.50
  • GRC $30.87
  • 52 Week High
  • RCUS $18.98
  • GRC $44.56
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 66.27
  • GRC 58.68
  • Support Level
  • RCUS $11.30
  • GRC $42.76
  • Resistance Level
  • RCUS $12.05
  • GRC $43.98
  • Average True Range (ATR)
  • RCUS 0.58
  • GRC 0.87
  • MACD
  • RCUS 0.02
  • GRC -0.04
  • Stochastic Oscillator
  • RCUS 81.30
  • GRC 63.96

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

Share on Social Networks: